Statement of Federal Trade Commission Chairman Jon Leibowitz on Ending Pay-for-Delay Drug Settlements, Praises Inclusion in Presidents Health Care Proposal

Share This Page

For Release

“When drug companies agree not to compete, consumers lose,” said Federal Trade Commission Chairman Jon Leibowitz. “Ending pay-for-delay settlements will help control drug costs. We’re delighted about the President’s resolute support for this bipartisan initiative.”

(JDL stmt)

Contact Information

MEDIA CONTACT:
Office of Public Affairs
202-326-2181